Page last updated: 2024-08-24

pivalyloxymethyl butyrate and Adenocarcinoma

pivalyloxymethyl butyrate has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cutts, SM; Hmelnitsky, I; Nudelman, A; Phillips, DR; Rephaeli, A	1

Other Studies

1 other study(ies) available for pivalyloxymethyl butyrate and Adenocarcinoma

Article	Year
Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9). Cancer research, 2001, Nov-15, Volume: 61, Issue:22 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Breast Neoplasms; Butyrates; DNA Adducts; Doxorubicin; Drug Administration Schedule; Drug Synergism; Formaldehyde; Humans; Neuroblastoma; Prodrugs; Tumor Cells, Cultured	2001

Article

Year

Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9).

Cancer research, 2001, Nov-15, Volume: 61, Issue:22

Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Breast Neoplasms; Butyrates; DNA Adducts; Doxorubicin; Drug Administration Schedule; Drug Synergism; Formaldehyde; Humans; Neuroblastoma; Prodrugs; Tumor Cells, Cultured

2001